First Manufacturer to Receive New Official Approval of the e-Health Card in Germany

On October 1 2011, Germany will begin the country-wide distribution of its new electronic health card. Morpho (Safran group) is the first manufacturer to have received official approval for production of the card. This was confirmed by gematik (Gesellschaft für Telematikanwendungen der Gesundheitskarte) - the German association for telematics applications for the e-health card. This means that Morpho can now make the approved e-health card available to health insurers for upcoming distribution. By the end of the year, 10% of all insured persons will receive the new card.

The new e-health card, called "Generation 1plus", is already suited for future online use and has high-security encryption functions.

The production facility at the German manufacturing site in Flintbek near Kiel has successfully implemented the required security measures and is ready to start production. One in three persons in Germany insured under a statutory health insurance program will receive an e-health card produced in Flintbek. That makes Morpho one of the market leaders in terms of the total volume of electronic health cards.

"We are pleased to be the first company to have received full approval for our Generation 1plus e-health card which will be ready for the launch of distribution. At the same time, we are sure the initial rollout will pave the way for a full rollout in 2012 and in subsequent years," said Christopher Goulet, Head of Sales for Central and Eastern Europe, Payment and ID Documents at Morpho, e-Documents Division.

About Morpho
Morpho, a high-technology company in the Safran group, is one of the world's leading suppliers of identification, detection and e-document solutions. Morpho is specialized in personal rights and flow management applications, in particular based on biometrics, a sector in which it is the world leader, as well as secure terminals and smart cards. Morpho's integrated systems and equipment are deployed worldwide and contribute to the safety and security of transportation, data, people and countries. Through its e-Documents Division, Morpho is a worldwide leader in identity documents and secure credentials. It delivers trust in the digital world through smart cards, passports, tokens, personalized and blank documents. The technology expertise of the e-Documents Division shapes the markets for the ID document, payment, telecoms and Identity Access Management segments. With 2,800 employees, worldwide subsidiaries and 6 production and 9 development centers, the Division is close to its customers all over the globe.

For more information: www.morpho.com

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...